Max Robotics — Global Service Robot Directory + US Certification

About

Paul Calle is a pioneering robotic surgeon whose work is reshaping the landscape of urologic oncology, with a particular focus on nephron-sparing surgery and minimally invasive techniques. His major contributions center on the clinical validation of the novel Hugo™ Robot-Assisted Surgery (RAS) system, a next-generation platform designed for enhanced modularity and flexibility. In his landmark 2024 study, Calle demonstrated the feasibility of robot-assisted partial nephrectomy using the Hugo RAS system in the first off-clamp series, achieving promising perioperative outcomes and setting a new benchmark for kidney cancer surgery. This work, already garnering 16 citations, underscores his role as an early adopter and evaluator of cutting-edge surgical technology. Additionally, Calle has explored the safety and feasibility of three-arm settings for robot-assisted radical prostatectomy using the same platform, further expanding the Hugo RAS system’s applications. His research not only advances surgical precision but also provides critical evidence for integrating modular robotic systems into routine practice. For students and researchers, Calle’s work exemplifies how rigorous clinical investigation can translate innovative engineering into tangible patient benefits, making him a key figure in the evolution of robotic urology.